Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Beauty Health (SKIN) Long-Term Debt Issuances (2020 - 2025)

Beauty Health (SKIN) has disclosed Long-Term Debt Issuances for 3 consecutive years, with -$85000.0 as the latest value for Q4 2025.

Quarterly Long-Term Debt Issuances changed N/A to -$85000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$701000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $237.6 million for FY2025, N/A changed from the prior year.
Long-Term Debt Issuances for Q4 2025 was -$85000.0 at Beauty Health, up from -$616000.0 in the prior quarter.
The five-year high for Long-Term Debt Issuances was $745.0 million in Q3 2021, with the low at -$745.0 million in Q4 2021.